Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Am J Intellect Dev Disabil. 2014 Jan;119(1):17–32. doi: 10.1352/1944-7558-119.1.17

Table 1.

Pre-experimental Characteristics by Dose Frequency Groups and Diagnoses.

Pre-treatment characteristic Group DS M(SD) NDS M(SD) d for dose frequency d for diagnosis
Chronological age in months LDF 22.50(3.09) 23.54(3.50)
HDF 21.62(2.61) 22.10(2.92)
Total 22.02(2.83) 22.85(3.26) .39 -.27

Bayley III mental age in months LDF 12.69(1.66) 12.20(2.54)
HDF 12.05(2.09) 13.36(1.86)
Total 12.34(1.91) 12.76(2.28) -.08 -.20

Bayley III CC LDF 65.94(6.38) 63.33(6.73)
HDF 63.95(7.18) 68.93(5.25)
Total 64.86(6.80) 66.03(6.60) -.21 -.17

Number of words spoken on MB-CDI LDF .94(1.34) 2.73(6.91)
HDF 1.37(1.61) .86(1.03)
Total 1.17(1.48) 1.83(5.03) .19 -.19

LDF = low dose frequency. HDF = high dose frequency. DS = Down syndrome. NDS = Non-Down syndrome intellectual disability. CC = Cognitive Composite standard score.